Abstract Research Article
edema (HAPE). In an ongoing study on the role of ONSD in HAPE, the right and left eye ONSD were measured in all the patients. A separate analysis to see the correlation between the recordings of ONSD for both the eyes was done independent of the status of underlying disease (i.e., HAPE).
The study population included all consecutive patients of HAPE admitted to the hospital during the study. Other inclusion criteria were (a) native lowlanders, (b) with no known comorbidities before induction, and (c) inducted to high altitude (more than 11,500 ft) either by road or air for occupational purposes. Exclusion criteria were (a) native highlanders, (b) any other illness associated with HAPE, (c) de-induction to low altitude during disease before remission of HAPE, and (d) lost to follow-up for any reason. The study was conducted from September 2012 to March 2013. The data were collected in a tertiary care hospital at an altitude of 11,500 ft. Informed consent was taken from the patients as per the revised ethical guidelines for human experimentation of Helsinki Declaration of 2000. [3] There is no reference standard for the index test. The test was performed to compare the concordance in the results of the test when performed in the right and left the eye. All patients (n = 47) underwent ONSU of both eyes using visual axis at admission and predefined intervals till discharge of the patient. In brief, the patient was placed in a supine position and asked to look upward to a point in the ceiling. He was asked to close his left eye, with his right eye focusing on the center point at the ceiling. Ultrasound gel was put in a hand glove, and the same was placed over the closed eye. 7.5 Hz probe of Fuji Sonosite M Turbo® was used, and ONSU was done in B-scan mode. The average time for each scan was one min. ONSD was measured postultrasound using onscreen calipers at 3 mm behind the globe, as it reflects the best measure of ICP. [4] ONSD was measured within 6 h of admission and after that every 24 h till day 10 (D10) of admission or until the day of discharge, whichever was earlier. ONSU was repeated in the same individual during various stages of the disease and after remission of disease. ONSD was done by a single investigator (primary author) who was not blinded to the diagnosis of HAPE. A random sample of 10 ONSU out of every 100 ONSU conducted by the primary author was counter checked by the radiologist independently, who was blinded to the primary diagnosis and the earlier measurements.
This study allows the comparison between both eyes in 256 recordings over a period of 10 days. The analysis was done using SPSS Statistics for Windows, version 17.0 (SPSS Inc, Chicago, Ill, USA), by Pearson's correlation and Student's t-test.
Results
The study group was managed uniformly for HAPE with supplemental oxygen therapy. A total of 64 participants developed HAPE during the study, out of which four patients were native highlanders, two had associated high altitude cerebral edema with HAPE, eight patients were de-inducted to lower altitude, and three were lost to follow-up due to associated comorbidities of hypertension (HTN), diabetes mellitus , and coronary artery disease, respectively. The remaining 47 patients, who were prospectively evaluated from the day of admission to discharge with ONSD of both eyes, were analyzed.
The mean (standard deviation) ONSD of the left eye was 4.60 (0.71) mm whereas the mean ONSD of right eye 4.59 (0.72) mm. The ONSD of the right eye and left eye was strongly correlated (correlation coefficient of 0.98 with P < 0.0001). The mean difference in the ONSD of both eyes (right-left) was −0.004 (0.114) mm which was not statistically significant. On regression analysis of ONSD of the right eye with the left eye and vice-versa, the coefficient of regression (R 2 ) was found to be 0.975 (P < 0.0001) [ Figures 1 and 2 ]. On comparison of the day-wise ONSD from the day of admission to the D10 of both eyes, ONSD from both eyes correlated well [ Table 1 ] and the differences were not statistically different during any phase of illness [ Table 2 ].
dIscussIon
The role of ONSD as a surrogate marker for raised ICP is well known. The studies have conclusively proven the role of increased ONSD in cases with intracranial HTN with reversal of ONSD on subsidence of increased ICP. [1, 2, 5] There are some contradicting reports of weak correlation of the ONSD in cases with increased ICP [6] which could be due to associated pitfalls when measuring ONSD during ONSU. [7] Many studies have employed the mean recording of both the eyes for ONSD [8] whereas some studies have measured in only one eye. The research primarily aimed at studying the difference in the right eye and left eye ONSD, which has not been well studied in the past. There was no statistically significant difference in the ONSD of either eye in our study. This corroborates with the studies already published in the past wherein there was no difference in the measurement of both the eyes. In a study by Maude et al. in healthy volunteers from Bangladesh, there was no difference in the individual mean measurements in the right eye and left eye (P = 0.12). [9] In another study on healthy infants and children by Ballantyne et al., there was no statistical difference in the right and left eye ONSD (P = 0.66). [10] In another prospective case-control study by Romagnuolo et al. in ten healthy volunteers, there was no significant difference in the ONSD of both eyes in supine or Trendelenburg position. [11] Our study included measurement of ONSD in both diseased patients and the same patients after the subsidence of the illness. This is a major strength as most of the previous studies were done only on healthy volunteers. In a similar study on the comparison of diseased patients with normal tension glaucoma and healthy volunteers, there was no statistically significant difference in ONSD of the right and left eyes in either group. [12] The mean ONSD shown above should not be considered as the mean of healthy individuals as it is a combination of diseased ONSD recordings and recordings on the same set of subjects on subsidence of disease. Thus, misinterpreting these ONSD as cutoff of healthy adult males or diseased adult males should be avoided as this study was not designed for the same.
The limitations of the study include the inclusion of only males; thus, any gender differences cannot be commented based on this study. Furthermore, the lack of a gold standard such as computed tomography (CT) scan or magnetic resonance imaging (MRI) to confirm the findings is also a limitation of the study. A separate well-designed study to measure the ONSD in healthy controls and diseased patients with simultaneous neuroimaging by CT/ MRI would validate the findings of our study better.
conclusIon
We can conclude based on the findings of this study that measurement of either eye is sufficient for bedside or research purposes as the differences in the ONSD in both eyes are statistically insignificant. This would help in saving the time of the examiner and discomfort to the patient.
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